Abstract
Continued advances in our understanding of the etiology, biology, and genetics of melanoma are likely to help curtail the rising incidence of melanoma. Likewise, progress in our understanding of the morphology of early melanoma and its growth dynamics together with continued development of effective therapies for advanced disease is likely to help decrease the morbidity and mortality rate associated with this cancer. This chapter will elucidate the factors that predispose individuals to melanoma and examine lesions that are considered to be potential melanoma precursor lesions. By identifying these high-risk patients and lesions, it is the hope that targeted interventions can be implemented to permit for the early detection of melanoma or for the prevention of this tumor. The phenotypic markers associated with a heightened risk of melanoma include the presence of many nevi and particularly of Clark nevi (large acquired nevi); the presence of BAP1-inactivated melanocytic tumors, as well as other phenotypic risk factors such as fair skin type, hair color, and eye color; and the presence of freckles and lentigines. While no obligate melanoma precursor lesions have yet been identified, there are some lesions, such as congenital nevi, that appear to have a higher than expected incidence of associated melanoma. The management of these high-risk patients and lesions will also be discussed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alikhan A, Ibrahimi OA, Eisen DB (2012) Congenital melanocytic nevi: where are we now? Part I Clinical presentation, epidemiology, pathogenesis, histology, malignant transformation, and neurocutaneous melanosis. J Am Acad Dermatol 67:495.e1–495.e17; quiz 512-494. https://doi.org/10.1016/j.jaad.2012.06.023
Andersen WK, Labadie RR, Bhawan J (1997) Histopathology of solar lentigines of the face: a quantitative study. J Am Acad Dermatol 36:444–447
Annessi G et al (2001) Correlation between clinical atypia and histologic dysplasia in acquired melanocytic nevi. J Am Acad Dermatol 45:77–85. https://doi.org/10.1067/mjd.2001.114580
Autier P, Koechlin A, Boniol M (2015) The forthcoming inexorable decline of cutaneous melanoma mortality in light-skinned populations. Eur J Cancer 51:869–878. https://doi.org/10.1016/j.ejca.2015.01.056
Bajaj S et al (2015) Growth-curve modeling of nevi with a peripheral globular pattern. JAMA Dermatol 151:1338–1345. https://doi.org/10.1001/jamadermatol.2015.2231
Banky JP, Kelly JW, English DR, Yeatman JM, Dowling JP (2005) Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma. Arch Dermatol 141:998–1006. https://doi.org/10.1001/archderm.141.8.998
Barkovich AJ, Frieden IJ, Williams ML (1994) MR of neurocutaneous melanosis. AJNR Am J Neuroradiol 15:859–867
Bastian BC, LeBoit PE, Pinkel D (2000) Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol 157:967–972. https://doi.org/10.1016/S0002-9440(10)64609-3
Bauer J, Curtin JA, Pinkel D, Bastian BC (2007) Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations. J Invest Dermatol 127:179–182. https://doi.org/10.1038/sj.jid.5700490
Bett BJ (2005) Large or multiple congenital melanocytic nevi: occurrence of cutaneous melanoma in 1008 persons. J Am Acad Dermatol 52:793–797. https://doi.org/10.1016/j.jaad.2005.02.024
Betti R, Inselvini E, Vergani R, Crosti C (2000) Small congenital nevi associated with melanoma: case reports and considerations. J Dermatol 27:583–590
Boniol M, Autier P, Gandini S (2015) Melanoma mortality following skin cancer screening in Germany. BMJ Open 5:e008158. https://doi.org/10.1136/bmjopen-2015-008158
Breitbart EW, Waldmann A, Nolte S, Capellaro M, Greinert R, Volkmer B, Katalinic A (2012) Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol 66:201–211. https://doi.org/10.1016/j.jaad.2010.11.016
Brod C, Schippert W, Breuninger H (2009) Dysplastic nevus syndrome with development of multiple melanomas. A surgical concept for prophylaxis. J Dtsch Dermatol Ges 7:773–775. https://doi.org/10.1111/j.1610-0387.2009.07095.x
Burnett MEM, Ashfaq A, Scope A (2012) Nevogenesis: changing theories. In: Marghoob A (ed) Nevogenesis, mechanisms and clinical implications of nevus development. Springer, Berlin/Heidelberg, pp 1–23. https://doi.org/10.1007/978-3-642-28397-0
Busam KJ, Kutzner H, Cerroni L, Wiesner T (2014) Clinical and pathologic findings of Spitz nevi and atypical Spitz tumors with ALK fusions. Am J Surg Pathol 38:925–933. https://doi.org/10.1097/PAS.0000000000000187
Campbell LB, Kreicher KL, Gittleman HR, Strodtbeck K, Barnholtz-Sloan J, Bordeaux JS (2015) Melanoma incidence in children and adolescents: decreasing trends in the United States. J Pediatr 166:1505–1513. https://doi.org/10.1016/j.jpeds.2015.02.050
Carrera C et al (2018) Clinical and dermoscopic characterization of pediatric and adolescent melanomas: multicenter study of 52 cases. J Am Acad Dermatol 78:278–288. https://doi.org/10.1016/j.jaad.2017.09.065
Castilla EE, da Graca Dutra M, Orioli-Parreiras IM (1981) Epidemiology of congenital pigmented naevi: I. Incidence rates and relative frequencies. Br J Dermatol 104:307–315
Clark WH Jr, Reimer RR, Greene M, Ainsworth AM, Mastrangelo MJ (1978) Origin of familial malignant melanomas from heritable melanocytic lesions. ‘The B-K mole syndrome’. Arch Dermatol 114:732–738
Cohen MH, Cohen BJ, Shotkin JD, Morrison PT (1991) Surgical prophylaxis of malignant melanoma. Ann Surg 213:308–314
DeDavid M et al (1997) A study of large congenital melanocytic nevi and associated malignant melanomas: review of cases in the New York University registry and the world literature. J Am Acad Dermatol 36:409–416
Elwood JM, Whitehead SM, Davison J, Stewart M, Galt M (1990) Malignant melanoma in England: risks associated with naevi, freckles, social class, hair colour, and sunburn. Int J Epidemiol 19:801–810
Fears TR et al (2006) Identifying individuals at high risk of melanoma: a practical predictor of absolute risk. J Clin Oncol 24:3590–3596. https://doi.org/10.1200/JCO.2005.04.1277
Fortes C et al (2010) Identifying individuals at high risk of melanoma: a simple tool. Eur J Cancer Prev 19:393–400. https://doi.org/10.1097/CEJ.0b013e32833b492f
Foster RD, Williams ML, Barkovich AJ, Hoffman WY, Mathes SJ, Frieden IJ (2001) Giant congenital melanocytic nevi: the significance of neurocutaneous melanosis in neurologically asymptomatic children. Plast Reconstr Surg 107:933–941
Frank SA (2007) Dynamics of cancer: incidence, inheritance, and evolution. Princeton University Press, Princeton
Fukunaga-Kalabis M, Herlyn M (2012) Cancer: complexion matters. Nature 491:342–343. https://doi.org/10.1038/nature11641
Fuller SR, Bowen GM, Tanner B, Florell SR, Grossman D (2007) Digital dermoscopic monitoring of atypical nevi in patients at risk for melanoma. Dermatol Surg 33:1198–1206; discussion 1205-1196. https://doi.org/10.1111/j.1524-4725.2007.33254.x
Gandini S, Sera F, Cattaruzza MS, Pasquini P, Abeni D, Boyle P, Melchi CF (2005a) Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 41:28–44. https://doi.org/10.1016/j.ejca.2004.10.015
Gandini S et al (2005b) Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer (Oxford, England: 1990) 41:2040–2059. https://doi.org/10.1016/j.ejca.2005.03.034
Glazer AM, Winkelmann RR, Farberg AS, Rigel DS (2016) Analysis of trends in US melanoma incidence and mortality. JAMA Derm. https://doi.org/10.1001/jamadermatol.2016.4512
Greene MH, Clark WH Jr, Tucker MA, Kraemer KH, Elder DE, Fraser MC (1985) High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med 102:458–465
Gudbjartsson DF et al (2008) ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat Genet 40:886–891. https://doi.org/10.1038/ng.161
Haenssle HA et al (2016) Association of patient risk factors and frequency of nevus-associated cutaneous melanomas. JAMA Dermatol 152:291–298. https://doi.org/10.1001/jamadermatol.2015.3775
Hale EK et al (2005) Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic naevi – results from the NYU-LCMN registry. Br J Dermatol 152:512–517. https://doi.org/10.1111/j.1365-2133.2005.06316.x
Halpern AC, Guerry D, Elder DE, Trock B, Synnestvedt M, Humphreys T (1993) Natural history of dysplastic nevi. J Am Acad Dermatol 29:51–57
Halpern AC, Marchetti MA, Marghoob AA (2014) Melanoma surveillance in “high-risk” individuals. JAMA Dermatol 150:815–816. https://doi.org/10.1001/jamadermatol.2014.513
Harris IS, Brugge JS (2015) Cancer: the enemy of my enemy is my friend. Nature 527:170–171. https://doi.org/10.1038/nature15644
Haugh AM et al (2017) Genotypic and phenotypic features of BAP1 cancer syndrome: a report of 8 new families and review of cases in the literature. JAMA Dermatol 153:999–1006. https://doi.org/10.1001/jamadermatol.2017.2330
Hawkes JE, Truong A, Meyer LJ (2016) Genetic predisposition to melanoma. Semin Oncol 43:591–597. https://doi.org/10.1053/j.seminoncol.2016.08.003
Hofmann-Wellenhof R, Marghoob AA, Zalaudek I (2016) Large acquired nevus or dysplastic nevus: what’s in the name of a nevus? JAMA Dermatol 152:623–624. https://doi.org/10.1001/jamadermatol.2015.6186
Ichii-Nakato N et al (2006) High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi. J Invest Dermatol 126:2111–2118. https://doi.org/10.1038/sj.jid.5700366
Idorn LW, Datta P, Heydenreich J, Philipsen PA, Wulf HC (2015) Black light visualized solar lentigines on the shoulders and upper back are associated with objectively measured UVR exposure and cutaneous malignant melanoma. Photochem Photobiol Sci 14:481–487. https://doi.org/10.1039/c4pp00332b
Illig L, Weidner F, Hundeiker M, Gartmann H, Biess B, Leyh F, Paul E (1985) Congenital nevi less than or equal to 10 cm as precursors to melanoma. 52 cases, a review, and a new conception. Arch Dermatol 121:1274–1281
Ingordo V, Gentile C, Iannazzone SS, Cusano F, Naldi L (2007) Congenital melanocytic nevus: an epidemiologic study in Italy. Dermatology 214:227–230. https://doi.org/10.1159/000099587
Kadonaga JN, Frieden IJ (1991) Neurocutaneous melanosis: definition and review of the literature. J Am Acad Dermatol 24:747–755
Kanada KN, Merin MR, Munden A, Friedlander SF (2012) A prospective study of cutaneous findings in newborns in the United States: correlation with race, ethnicity, and gestational status using updated classification and nomenclature. J Pediatr 161:240–245. https://doi.org/10.1016/j.jpeds.2012.02.052
Katalinic A et al (2012) Does skin cancer screening save lives?: an observational study comparing trends in melanoma mortality in regions with and without screening. Cancer 118:5395–5402. https://doi.org/10.1002/cncr.27566
Kinsler VA, Birley J, Atherton DJ (2009) Great Ormond Street Hospital for Children registry for congenital melanocytic naevi: prospective study 1988–2007. Part 1-epidemiology, phenotype and outcomes. Br J Dermatol 160:143–150. https://doi.org/10.1111/j.1365-2133.2008.08849.x
Kinsler VA et al (2013) Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. J Invest Dermatol 133:2229–2236. https://doi.org/10.1038/jid.2013.70
Kinsler VA et al (2017a) Melanoma in congenital melanocytic naevi. Br J Dermatol 176:1131–1143. https://doi.org/10.1111/bjd.15301
Kinsler VA, O’Hare P, Jacques T, Hargrave D, Slater O (2017b) MEK inhibition appears to improve symptom control in primary NRAS-driven CNS melanoma in children. Br J Cancer 116:990–993. https://doi.org/10.1038/bjc.2017.49
Kittler H, Tschandl P (2013) Dysplastic nevus: why this term should be abandoned in dermatoscopy. Dermatol Clin 31:579–588, viii. https://doi.org/10.1016/j.det.2013.06.009
Kittler H, Pehamberger H, Wolff K, Binder M (2000a) Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi. J Am Acad Dermatol 43:467–476. https://doi.org/10.1067/mjd.2000.107504
Kittler H, Seltenheim M, Dawid M, Pehamberger H, Wolff K, Binder M (2000b) Frequency and characteristics of enlarging common melanocytic nevi. Arch Dermatol 136:316–320
Kittler H et al (2006) Identification of clinically featureless incipient melanoma using sequential dermoscopy imaging. Arch Dermatol 142:1113–1119. https://doi.org/10.1001/archderm.142.9.1113
Klein LJ, Barr RJ (1990) Histologic atypia in clinically benign nevi. A prospective study. J Am Acad Dermatol 22:275–282
Kopf AW, Levine LJ, Rigel DS, Friedman RJ, Levenstein M (1985a) Congenital-nevus-like nevi, nevi spili, and cafe-au-lait spots in patients with malignant melanoma. J Dermatol Surg Oncol 11:275–280
Kopf AW, Levine LJ, Rigel DS, Friedman RJ, Levenstein M (1985b) Prevalence of congenital-nevus-like nevi, nevi spili, and cafe au lait spots. Arch Dermatol 121:766–769
Krengel S (2005) Nevogenesis – new thoughts regarding a classical problem. Am J Dermatopathol 27:456–465
Krengel S, Hauschild A, Schafer T (2006) Melanoma risk in congenital melanocytic naevi: a systematic review. Br J Dermatol 155:1–8. https://doi.org/10.1111/j.1365-2133.2006.07218.x
Krengel S, Scope A, Dusza SW, Vonthein R, Marghoob AA (2013) New recommendations for the categorization of cutaneous features of congenital melanocytic nevi. J Am Acad Dermatol 68:441–451. https://doi.org/10.1016/j.jaad.2012.05.043
Lallas A et al (2015) Likelihood of finding melanoma when removing a Spitzoid-looking lesion in patients aged 12 years or older. J Am Acad Dermatol 72:47–53. https://doi.org/10.1016/j.jaad.2014.09.037
Lallas A et al (2017) Update on dermoscopy of Spitz/reed naevi and management guidelines by the international dermoscopy society. Br J Dermatol 177:645–655. https://doi.org/10.1111/bjd.15339
Lallas A, Apalla Z, Papageorgiou C, Evangelou G, Ioannides D, Argenziano G (2018) Management of Flat Pigmented Spitz and Reed Nevi in Children.JAMA Dermatol 154(11):1353–1354
Liotta LA, Kohn EC (2003) Cancer’s deadly signature. Nat Genet 33:10–11. https://doi.org/10.1038/ng0103-10
Liu W et al (2005) What features do patients notice that help to distinguish between benign pigmented lesions and melanomas?: the ABCD(E) rule versus the seven-point checklist. Melanoma Res 15:549–554
Liu W, Dowling JP, Murray WK, McArthur GA, Thompson JF, Wolfe R, Kelly JW (2006) Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas. Arch Dermatol 142:1551–1558. https://doi.org/10.1001/archderm.142.12.1551
Marghoob AA et al (1994) Risk of cutaneous malignant melanoma in patients with ‘classic’ atypical-mole syndrome. A case-control study. Arch Dermatol 130:993–998
Marghoob AA, Dusza S, Oliveria S, Halpern AC (2004) Number of satellite nevi as a correlate for neurocutaneous melanocytosis in patients with large congenital melanocytic nevi. Arch Dermatol 140:171–175. https://doi.org/10.1001/archderm.140.2.171
McLean DI, Gallagher RP (1995) “Sunburn” freckles, cafe-au-lait macules, and other pigmented lesions of schoolchildren: the Vancouver Mole Study. J Am Acad Dermatol 32:565–570
Menzies SW, Gutenev A, Avramidis M, Batrac A, McCarthy WH (2001) Short-term digital surface microscopic monitoring of atypical or changing melanocytic lesions. Arch Dermatol 137:1583–1589
Mitra D et al (2012) An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background. Nature 491:449–453. https://doi.org/10.1038/nature11624
Moawad S et al (2018) Clinical, dermoscopic, histological and molecular analysis of BAP1 inactivated melanocytic nevus/tumor in two familial cases of BAP1 syndrome. Br J Dermatol. https://doi.org/10.1111/bjd.16740
Moloney FJ et al (2014) Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study. JAMA Dermatol 150:819–827. https://doi.org/10.1001/jamadermatol.2014.514
Morgan AM, Lo J, Fisher DE (2013) How does pheomelanin synthesis contribute to melanomagenesis?: two distinct mechanisms could explain the carcinogenicity of pheomelanin synthesis. BioEssays 35:672–676. https://doi.org/10.1002/bies.201300020
Neuhold JC, Friesenhahn J, Gerdes N, Krengel S (2015) Case reports of fatal or metastasizing melanoma in children and adolescents: a systematic analysis of the literature. Pediatr Dermatol 32:13–22. https://doi.org/10.1111/pde.12400
Newton-Bishop JA et al (2010) Melanocytic nevi, nevus genes, and melanoma risk in a large case-control study in the United Kingdom. Cancer Epidemiology Biomarkers Prev 19:2043–2054. https://doi.org/10.1158/1055-9965.epi-10-0233
Nicholls EM (1973) Development and elimination of pigmented moles, and the anatomical distribution of primary malignant melanoma. Cancer 32:191–195
Oliveria SA, Yagerman SE, Jaimes N, Goodwin AI, Dusza SW, Halpern AC, Marghoob AA (2013) Clinical and dermoscopic characteristics of new naevi in adults: results from a cohort study. Br J Dermatol 169:848–853. https://doi.org/10.1111/bjd.12482
Osterlind A, Tucker MA, Hou-Jensen K, Stone BJ, Engholm G, Jensen OM (1988) The Danish case-control study of cutaneous malignant melanoma. I. Importance of host factors. Int J Cancer 42:200–206
Pampena R, Kyrgidis A, Lallas A, Moscarella E, Argenziano G, Longo C (2017) A meta-analysis of nevus-associated melanoma: prevalence and practical implications. J Am Acad Dermatol 77:938–945 e934. https://doi.org/10.1016/j.jaad.2017.06.149
Piskounova E et al (2015) Oxidative stress inhibits distant metastasis by human melanoma cells. Nature 527:186–191. https://doi.org/10.1038/nature15726
Potrony M, Badenas C, Aguilera P, Puig-Butille JA, Carrera C, Malvehy J, Puig S (2015) Update in genetic susceptibility in melanoma. Ann Transl Med 3:210. https://doi.org/10.3978/j.issn.2305-5839.2015.08.11
Puig S et al (2007) Melanomas that failed dermoscopic detection: a combined clinicodermoscopic approach for not missing melanoma. Dermatol Surg 33:1262–1273. https://doi.org/10.1111/j.1524-4725.2007.33264.x
Raimondi S, Sera F, Gandini S, Iodice S, Caini S, Maisonneuve P, Fargnoli MC (2008) MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int J Cancer 122:2753–2760. https://doi.org/10.1002/ijc.23396
Rajadhyaksha M, Marghoob A, Rossi A, Halpern AC, Nehal KS (2017) Reflectance confocal microscopy of skin in vivo: from bench to bedside. Lasers Surg Med 49:7–19. https://doi.org/10.1002/lsm.22600
Ramaswamy S, Ross KN, Lander ES, Golub TR (2003) A molecular signature of metastasis in primary solid tumors. Nat Genet 33:49–54. https://doi.org/10.1038/ng1060
Rhodes AR (1986) Melanocytic precursors of cutaneous melanoma. Estimated risks and guidelines for management. Med Clin North Am 70:3–37
Roesch A, Burgdorf W, Stolz W, Landthaler M, Vogt T (2006) Dermatoscopy of “dysplastic nevi”: a beacon in diagnostic darkness. Eur J Dermatol 16:479–493
Rogers T, Marino ML, Raciti P, Jain M, Busam KJ, Marchetti MA, Marghoob AA (2016) Biologically distinct subsets of nevi. G Ital Dermatol Venereol 151:365–384
Roh MR, Eliades P, Gupta S, Tsao H (2015) Genetics of melanocytic nevi. Pigment Cell Melanoma Res 28:661–672. https://doi.org/10.1111/pcmr.12412
Roider EM, Fisher DE (2016) Red hair, light skin, and UV-independent risk for melanoma development in humans. JAMA Dermatol 152:751–753. https://doi.org/10.1001/jamadermatol.2016.0524
Rosendahl CO, Grant-Kels JM, Que SK (2015) Dysplastic nevus: fact and fiction. J Am Acad Dermatol 73:507–512. https://doi.org/10.1016/j.jaad.2015.04.029
Salerni G et al (2012a) Characterization of 1152 lesions excised over 10 years using total-body photography and digital dermatoscopy in the surveillance of patients at high risk for melanoma. J Am Acad Dermatol 67:836–845. https://doi.org/10.1016/j.jaad.2012.01.028
Salerni G et al (2012b) Benefits of total body photography and digital dermatoscopy (“two-step method of digital follow-up”) in the early diagnosis of melanoma in patients at high risk for melanoma. J Am Acad Dermatol 67:e17–e27. https://doi.org/10.1016/j.jaad.2011.04.008
Salerni G, Terán T, Puig S, Malvehy J, Zalaudek I, Argenziano G, Kittler H (2013) Meta-analysis of digital dermoscopy follow-up of melanocytic skin lesions: a study on behalf of the international dermoscopy society. J Eur Acad Dermatol Venereol 27:805–814. https://doi.org/10.1111/jdv.12032
Schafer T, Merkl J, Klemm E, Wichmann HE, Ring J, KORA Study Group (2006) The epidemiology of nevi and signs of skin aging in the adult general population: results of the KORA-survey 2000. J Invest Dermatol 126:1490–1496. https://doi.org/10.1038/sj.jid.5700269
Scope A et al (2011) Clinical and dermoscopic stability and volatility of melanocytic nevi in a population-based cohort of children in Framingham school system. J Invest Dermatol 131:1615–1621. https://doi.org/10.1038/jid.2011.107
Scope A et al (2016) The study of nevi in children: principles learned and implications for melanoma diagnosis. J Am Acad Dermatol 75:813–823. https://doi.org/10.1016/j.jaad.2016.03.027
Sepehr A et al (2011) Long-term outcome of Spitz-type melanocytic tumors. Arch Dermatol 147:1173–1179. https://doi.org/10.1001/archdermatol.2011.170
Shain AH et al (2015) The genetic evolution of melanoma from precursor lesions the New England. J Med 373:1926–1936. https://doi.org/10.1056/NEJMoa1502583
Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7–30. https://doi.org/10.3322/caac.21442
Soura E, Eliades PJ, Shannon K, Stratigos AJ, Tsao H (2016) Hereditary melanoma: update on syndromes and management: genetics of familial atypical multiple mole melanoma syndrome. J Am Acad Dermatol 74:395–407; quiz 408-310. https://doi.org/10.1016/j.jaad.2015.08.038
Stern JB, Peck GL, Haupt HM, Hollingsworth HC, Beckerman T (1993) Malignant melanoma in xeroderma pigmentosum: search for a precursor lesion. J Am Acad Dermatol 28:591–594
Sturm RA et al (2003) The role of melanocortin-1 receptor polymorphism in skin cancer risk phenotypes. Pigment Cell Res 16:266–272
Tan JM et al (2017) The BRAF and NRAS mutation prevalence in dermoscopic subtypes of acquired naevi reveals constitutive mitogen-activated protein kinase pathway activation. Br J Dermatol. https://doi.org/10.1111/bjd.15809
Terushkin V et al (2012) Changes observed in slow-growing melanomas during long-term dermoscopic monitoring. Br J Dermatol 166:1213–1220. https://doi.org/10.1111/j.1365-2133.2012.10846.x
Truong A, Strazzulla L, March J, Boucher KM, Nelson KC, Kim CC, Grossman D (2016) Reduction in nevus biopsies in patients monitored by total body photography. J Am Acad Dermatol 75:135–143.e135. https://doi.org/10.1016/j.jaad.2016.02.1152
Tsao H, Bevona C, Goggins W, Quinn T (2003) The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based estimate. Arch Dermatol 139:282–288
Tucker MA et al (2002) A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families. Cancer 94:3192–3209. https://doi.org/10.1002/cncr.10605
Uribe P, Wistuba II, Gonzalez S (2003) BRAF mutation: a frequent event in benign, atypical, and malignant melanocytic lesions of the skin. Am J Dermatopathol 25:365–370
Vallone MG et al (2018) Melanocortin 1 receptor (MC1R) polymorphisms’ influence on size and dermoscopic features of nevi. Pigment Cell Melanoma Res 31:39–50. https://doi.org/10.1111/pcmr.12646
Valverde P, Healy E, Jackson I, Rees JL, Thody AJ (1995) Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet 11:328–330. https://doi.org/10.1038/ng1195-328
Vogelstein B et al (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319:525–532. https://doi.org/10.1056/NEJM198809013190901
Waelchli R, Aylett SE, Atherton D, Thompson DJ, Chong WK, Kinsler VA (2015a) Classification of neurological abnormalities in children with congenital melanocytic naevus syndrome identifies magnetic resonance imaging as the best predictor of clinical outcome. Br J Dermatol 173:739–750. https://doi.org/10.1111/bjd.13898
Waelchli R et al (2015b) Growth and hormone profiling in children with congenital melanocytic naevi. Br J Dermatol 173:1471–1478. https://doi.org/10.1111/bjd.14091
Walton RG, Jacobs AH, Cox AJ (1976) Pigmented lesions in newborn infants. Br J Dermatol 95:389–396
Weeraratna AT (2012) RAF around the edges – the paradox of BRAF inhibitors. N Engl J Med 366:271–273. https://doi.org/10.1056/NEJMe1111636
Wendt J, Mueller C, Rauscher S, Fae I, Fischer G, Okamoto I (2018) Contributions by MC1R variants to melanoma risk in males and females. JAMA Dermatol. https://doi.org/10.1001/jamadermatol.2018.1252
White E, Kirkpatrick CS, Lee JA (1994) Case-control study of malignant melanoma in Washington State. I Constitutional factors and sun exposure. Am J Epidemiol 139:857–868
Wiecker TS, Luther H, Buettner P, Bauer J, Garbe C (2003) Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood: a risk factor study in 1,812 kindergarten children. Cancer 97:628–638. https://doi.org/10.1002/cncr.11114
Wiesner T et al (2011) Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet 43:1018–1021. https://doi.org/10.1038/ng.910
Wiesner T, Murali R, Fried I, Cerroni L, Busam K, Kutzner H, Bastian BC (2012) A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. Am J Surg Pathol 36:818–830. https://doi.org/10.1097/PAS.0b013e3182498be5
Wiesner T et al (2014) Kinase fusions are frequent in Spitz tumours and spitzoid melanomas. Nat Commun 5:3116. https://doi.org/10.1038/ncomms4116
Williams LH, Shors AR, Barlow WE, Solomon C, White E (2011) Identifying persons at highest risk of melanoma using self-assessed risk factors. J Clin Exp Dermatol Res 2. https://doi.org/10.4172/2155-9554.1000129
Yagerman SE, Chen L, Jaimes N, Dusza SW, Halpern AC, Marghoob A (2014) ‘Do UC the melanoma?’ Recognising the importance of different lesions displaying unevenness or having a history of change for early melanoma detection. Australas J Dermatol 55:119–124. https://doi.org/10.1111/ajd.12143
Zaal LH, Mooi WJ, Klip H, van der Horst CM (2005) Risk of malignant transformation of congenital melanocytic nevi: a retrospective nationwide study from the Netherlands. Plast Reconstr Surg 116:1902–1909
Zalaudek I et al (2010) Who benefits from prophylactic surgical removal of “dysplastic” nevi? J Dtsch Dermatol Ges 8:279–280. https://doi.org/10.1111/j.1610-0387.2010.07377.x
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Navarrete-Dechent, C., Scope, A., Tsao, H., Marghoob, N.G., Sober, A.J., Marghoob, A.A. (2020). Acquired Precursor Lesions and Phenotypic Markers of Increased Risk for Cutaneous Melanoma. In: Balch, C., et al. Cutaneous Melanoma. Springer, Cham. https://doi.org/10.1007/978-3-030-05070-2_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-05070-2_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-05068-9
Online ISBN: 978-3-030-05070-2
eBook Packages: MedicineReference Module Medicine